Cheng-Hua Jin is an associate professor in the college of pharmacy at Yanbian University in China. Dr. Jin received his BS in Pharmacy from Yanbian University in China in 1998, and received his MS and PhD degrees in Medicinal Chemistry from Sungkyunkwan University in South Korea in 2001 and 2005, respectively. Dr. Jin’s interests are focused on the design, synthesis, and activity studies of anticancer, anti-fibrosis and antimicrobial small-molecule compounds. He has published more than 60 papers and patents, including more than 50 SCI papers and 10 patents. In recent years, He invented the anti-tumor drug EW-7197 (Vactosertib), which was approved by the US FDA in April 2014, and is currently in the clinical phase II research stage (USA).